openPR Logo
Press release

Global Personalized Cancer Vaccine Market | Immunotherapy Leads Innovation | Top Most Keyplayers -Genocea Biosciences, Inc., Advaxis Inc, BioNtech S E, Celldex Therapeutics

06-16-2025 09:04 AM CET | Health & Medicine

Press release from: DataM Intelligence 4 Market Research LLP

Personalized Cancer Vaccine Market

Personalized Cancer Vaccine Market

The Global Personalized Cancer Vaccines Market is expected to reach growth at a significant CAGR during the forecast period (2024-2031).

Personalized Cancer Vaccines Market is comprehensively covered in the DataM Intelligence report, which offers critical data, industry trends, and market intelligence. The study delves into the competitive environment, assessing leading players on their product portfolios, pricing, financial health, strategic growth initiatives, and geographic expansion.

Unlock exclusive insights with our detailed sample report (Please enter your Corporate Email ID to get priority access) @ https://datamintelligence.com/download-sample/personalized-cancer-vaccines-market?ca

Personalized cancer vaccines are a cutting-edge immunotherapy designed to stimulate a patient's immune system to recognize and attack cancer cells based on their unique genetic mutations. These vaccines are developed using tumor-specific neoantigens identified through genomic sequencing, allowing for highly targeted and individualized treatment. By enhancing the body's natural defenses, personalized cancer vaccines offer promising potential to improve outcomes, reduce recurrence, and complement existing therapies like checkpoint inhibitors.

Major players in the Personalized Cancer Vaccines market

The prominent players in Personalized Cancer Vaccines market research report are: Genocea Biosciences, Inc., Advaxis Inc, BioNtech S E, Celldex Therapeutics, Bristol-Myers Squibb, Genentech, Gritstone Oncology, Merck & Co, Moderna Therapeutics, Neon Therapeutics.

The companies are primarily focusing on strategies such as new product launches to penetrate the fastest-growing emerging markets across the world.

Personalized Cancer Vaccines Market Key Development

➤ BioNTech and Sanofi are evaluating SAR441000 (BNT131) in a Phase 1 basket trial as a monotherapy for advanced melanoma and in combination with anti-PD-1/PD-L1 inhibitors for advanced melanoma and select solid tumors.

Speak to Our Senior Analyst and Get Customization in the report as per your requirements @ https://datamintelligence.com/customize/personalized-cancer-vaccines-market?ca

Personalized Cancer Vaccines Market Segments

By Cancer Type: Cervical Cancer, Prostate Cancer, Glioblastoma, Others

By Vaccine Type: Peptide-based Vaccine, Dendritic Cell Vaccine, DNA & RNA Vaccine, Others

By End-User: Hospitals, Cancer research centers, Clinics, Others

The Personalized Cancer Vaccines industry is experiencing rapid growth, driven by advancements in medical technologies, increased demand for innovative therapies, and a rising focus on patient-centered care. As these sectors evolve, the need for comprehensive market analysis becomes crucial to understand trends, regulatory changes, and emerging opportunities.

Regions Covered:

The global Personalized Cancer Vaccines Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa.

☞ North America - US, Canada, Mexico

☞ Europe- Germany, Russia, UK, France, Italy, Rest of Europe

☞ Asia Pacific- China, India, Japan, Australia, Rest of Asia Pacific

☞ South America- Brazil, Argentina, Colombia, Rest of South America

☞ Middle East and Africa- Saudi Arabia, UAE, Oman, Bahrain, Qatar, Kuwait, Israel

This Report Covers:

✔ Go-to-market Strategy.

✔ Neutral perspective on the market performance.

✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, Market Access, and other significant analysis, as well as development status.

✔Customized regional/country reports as per request and country level analysis.

✔ Potential & niche segments and regions exhibiting promising growth covered.

✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Personalized Cancer Vaccine Market | Immunotherapy Leads Innovation | Top Most Keyplayers -Genocea Biosciences, Inc., Advaxis Inc, BioNtech S E, Celldex Therapeutics here

News-ID: 4067598 • Views:

More Releases from DataM Intelligence 4 Market Research LLP

Breakthrough Nutritional Ingredients Poised to Capture USD 325.4 Billion by 2031, Driven by Supplements and Functional Foods Demand | DataM Intelligence
Breakthrough Nutritional Ingredients Poised to Capture USD 325.4 Billion by 2031 …
The Global Nutritional Ingredients Market was valued at USD 182.5 billion in 2022 and is projected to reach USD 325.4 billion by 2031, growing at a CAGR of 7.5% during the forecast period 2024-2031. This robust growth is driven by a profound and global consumer shift towards health and wellness, the accelerating adoption of vegan and plant-based lifestyles, an aging global population seeking preventative nutrition, and the rapid expansion of
United States Aluminum Powder Market to Hit $3.71 Billion by 2032 | Leading companies - Toyal America Inc, Hunan Ningxiang Jiweixin Metal Powder Co., Ltd., ECKA Granules
United States Aluminum Powder Market to Hit $3.71 Billion by 2032 | Leading comp …
Leander, Texas and Tokyo, Japan - Dec.10.2025 As per DataM intelligence research report" Global Aluminum Powder Market Size reached US$ 7.32 billion in 2024 and is expected to reach US$ 12.39 billion by 2032, growing with a CAGR of 6.80% during the forecast period 2025-2032." Lightweight materials demand and additive manufacturing growth are boosting aluminum powder usage. Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/aluminum-powder-market?Prasad United States: Recent Industry
North America Non-Steroidal Anti-Inflammatory Drugs Market to Reach $17.27 Billion by 2033 | Leading companies - Bayer AG, Haleon group of companies, Kenvue, Teva Pharmaceutical Industries Ltd
North America Non-Steroidal Anti-Inflammatory Drugs Market to Reach $17.27 Billi …
Leander, Texas and Tokyo, Japan - Dec.10.2025 As per DataM intelligence research report" The North America non-steroidal anti-inflammatory drugs market size reached US$ 8.34 billion in 2024 and is expected to reach US$ 17.27 billion by 2033, growing at a CAGR of 7.6% during the forecast period 2025-2033." Chronic pain prevalence and OTC self-care trends continue to strengthen the NSAIDs market. Download your exclusive sample report today: (corporate email gets priority access):
United States Gene Therapy Market to Hit $6510.45 Million by 2033 | Leading companies - Alnylam Pharmaceuticals, Inc., NOVARTIS AG, Sarepta Therapeutics, Inc.
United States Gene Therapy Market to Hit $6510.45 Million by 2033 | Leading comp …
Leander, Texas and Tokyo, Japan - Dec.10.2025 As per DataM intelligence research report" The US Gene Therapy Market Size reached US$ 2,812.92 million in 2024 and is expected to reach US$ 21,701.51 million by 2033, growing at a CAGR of 23.5 % during the forecast period 2025-2033." Advances in viral vectors and precision medicine are driving rapid progress in the US gene therapy market. Download your exclusive sample report today: (corporate

All 5 Releases


More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose. Increase in incidence of target diseases like cancer is key driving factor which is expected to boost
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business. Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports. Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For